Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 6/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.50 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.50 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.50 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.49 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 5/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23430509 | 0.83 | ALDH1A1 (0.56) | ALDH1A1SRD5A2L3MBTL1ATMTDP1 | |
| SCHEMBL314267 | 0.81 | ALDH1A1 (0.93) | ALDH1A1SRD5A2L3MBTL1ATMTDP1 | |
| SCHEMBL9066312 | 0.81 | ALDH1A1 (0.93) | ALDH1A1SRD5A2L3MBTL1ATMTDP1 | |
| SCHEMBL1194001 | 0.79 | TSHR (0.60) | ALDH1A1SRD5A2AKR1C3AKR1C2CES2 | |
| Benzophenone SCHEMBL1074283 | 0.78 | ALDH1A1 (1.00) | ALDH1A1SRD5A2L3MBTL1ATMTDP1 | |
| Benzophenone SCHEMBL30537001 | 0.78 | ALDH1A1 (1.00) | ALDH1A1SRD5A2L3MBTL1ATMTDP1 | |
| Benzophenone SCHEMBL28491203 | 0.78 | ALDH1A1 (1.00) | ALDH1A1SRD5A2L3MBTL1ATMTDP1 | |
| Benzophenone SCHEMBL28180817 | 0.78 | ALDH1A1 (1.00) | ALDH1A1SRD5A2L3MBTL1ATMTDP1 | |
| Benzophenone SCHEMBL6061130 | 0.78 | ALDH1A1 (1.00) | ALDH1A1SRD5A2L3MBTL1ATMTDP1 | |
| Benzophenone SCHEMBL30536983 | 0.78 | ALDH1A1 (1.00) | ALDH1A1SRD5A2L3MBTL1ATMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678632-A1 | METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP | AGC Inc. (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-20250346557-A1 | METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP | AGC Inc. (JP) | 2025-11-13 | — | — | US | disclosed |
| WO-2024185814-A1 | METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP | ＡＧＣ株式会社 | 2024-09-12 | — | — | WO | disclosed |
| US-20210163408-A1 | METHOD FOR PREPARING A POLYFLUORINATED COMPOUND | ETH ZURICH (CH) | 2021-06-03 | — | — | US | disclosed |
| WO-2019229103-A1 | METHOD FOR PREPARING A POLYFLUORINATED COMPOUND | ETH ZURICH (CH) | 2019-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346557-A1 | METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP | STS, TST, CYP3A5 | ALDH1A1 358/4885SRD5A2 60/4885L3MBTL1 2574/4885 |
| US-20210163408-A1 | METHOD FOR PREPARING A POLYFLUORINATED COMPOUND | AFF4, AR, AFF2 | ALDH1A1 4317/4885SRD5A2 81/4885L3MBTL1 3072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.